# Fecal Microbial Transplant in Pediatric Crohn's Disease

> **NCT02272868** · PHASE1,PHASE2 · TERMINATED · sponsor: **Seattle Children's Hospital** · enrollment: 7 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **BIOLOGICAL:** Fecal Microbial transplant
- **DRUG:** Normal Saline
- **DRUG:** rifaximin+omeprazole+miralax

## Key facts

- **NCT ID:** NCT02272868
- **Lead sponsor:** Seattle Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2016-10-01
- **Final completion:** 2016-10-01
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02272868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02272868, "Fecal Microbial Transplant in Pediatric Crohn's Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02272868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*